Chennai sero-survey reports 21.5% have Coronavirus Antibodies


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Chennai sero-survey reports 21.5% have Coronavirus Antibodies
In Chennai 12405 were found seropositive

One-fifth of the Chennai's population has been exposed to SARS-CoV-2, the virus that causes Covid 19, according to the preliminary findings of the population-based sero survey in the
Chennai Corporation limits.

Of the 12,405 individuals, across 51 wards, tested for antibody against SARS-CoV-2, 2,673 people had evidence of exposure with a seroprevalence of 21.5%.

Of the 12,405 persons, only 173 had a history of contact with a Covid 19 patient.

The survey was carried out by the National Institute of Epidemiology and the field data collection for this took place between July 18-28. The test positivity rate at the end of July was around 10%.

Seroprevalence is the percentage of individuals of the population to have antibodies against SARS-Cov-2.

"Around 80% of the population is still susceptible to SARS-CoV-2 ingestion in Chennai," the sero survey report, released by the Chennai Corporation on Tuesday, stated.

However, it was found that seroprevalence varied vastly across various zones of Chennai Corporation.

For instance, 44.2% of the samples tested for the survey in Tondiarpet zone were found positive for IgG antibodies against SARS-Cov-2, which means that they have had previous exposure to the virus.

On the other hand, only 7.1% of those tested for the antibodies in the Madhavaram zone were found to have them.

Royapuram, another high-incidence zone, also recorded high seroprevalence of 34.4%. The Perungudi zone was found to have low seroprevalence of 7.3%.

"We need to understand the reasons for varying seroprevalence across zones to improve our control measures," the survey stated.

The ward-wise break up showed that Korukkpet (Ward 47), had 50% seroprevalence. New Washermanpet (Ward 39) had 49% seroprevalence while Mugalivakam (Ward 156) and Lakshmipuram (Ward 32) had the lowest seroprevalence of 2% and 3% respectively.

Meanwhile, out of the overall seroprevalence, women were found to have a higher percentage of seroprevalence (23.7%) when compared to men (19.3%). Across age groups, those between the ages of 10 and 19 had higher seroprevalence of 23.8% whereas those above the age of 60 had the lowest (15.9%).

The results also showed that the Infection to Case ratio (the number of cases of a disease compared to the number of infections with the agent that causes the disease) for the period of 14 July was 22.4%.

This, the survey said, was lower compared to some published studies, indicating high testing.

Apart from this, around 1.35 lakh people in Chennai have been tested positive for Covid 19 out of which 1.19 lakh have recovered as on Tuesday.

Addressing reporters, Chennai Corporation Commissioner G Prakash said that such seroprevalence surveys will continue.

"Wherever seroprevalence is high, reflection of (Covid 19) cases is lower. We can see that they are now stabilising in these areas- this is a natural outcome, the transmission speed will come down where
seroprevalence is high," he said.

"This was done 35 days ago, the seroprevalence will be higher now. It is important to know this because it is only then we will be able to balance interventions. We can increase interventions where seroprevalence is low," he added.

Story Source : https://www.newindianexpress.com 

Tags : #Chennai #SeropostiveChennai #Royapuram #korukkpet #NationalInstituteofEpidimiology #latestChennaiCovidNewsSep2 #GPrakash

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

The Value of Risk Communication in Public HealthOctober 08, 2026
What Makes a Reliable Health Screening Programme?October 08, 2026
How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026